We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 90

The impact of Dodd-Frank and EMIR in APAC: developments in Hong Kong and Singapore

  • InsightLegal Asia Consulting
  • -
  • European Union, Hong Kong, Singapore, USA
  • -
  • March 12 2014

G-20 regulatory authorities (in particular the US and EU) have launched many initiatives aimed at over-the-counter ("OTC") derivatives, some of which

Hong Kong Companies Ordinance

  • Bryan Cave LLP
  • -
  • Hong Kong, USA
  • -
  • March 13 2014

With the imminent commencement of the new Companies Ordinance on 3rd March 2014, we have highlighted 12 important changes as follows: Restriction on

International regulatory update

  • Clifford Chance LLP
  • -
  • Belgium, European Union, Germany, Global, Hong Kong, Japan, Netherlands, Singapore, South Korea, United Kingdom, USA
  • -
  • July 4 2011

The FSA has published a document setting out its initial thinking on how the Financial Conduct Authority (FCA), which is expected to be established by end-2012, will approach the delivery of its objectives

A comparative regulatory guide to listing in Hong Kong, London, New York and Toronto

  • Dorsey & Whitney LLP
  • -
  • Canada, Hong Kong, United Kingdom, USA
  • -
  • February 10 2010

There are two listing standards for NYSE: the Non-U.S. Standards for non-U.S. companies (which is further subdivided into two sets of standards worldwide and domestic under which non-U.S. companies may qualify for listing) and the U.S. Standards for domestic companies

RMB bond issue in Hong Kong (a.k.a. a delicious dim sum offering!) some structural issues to consider part 4

  • Dorsey & Whitney LLP
  • -
  • China, Hong Kong, USA
  • -
  • January 16 2014

Foreign and Chinese companies seeking to access the renminbi (“RMB”) bond market can now raise capital without time-consuming IPOs, rights issuances

International Regulatory Update 23-27 September 2013

  • Clifford Chance LLP
  • -
  • Australia, China, European Union, Germany, Global, Guernsey, Hong Kong, Japan, Luxembourg, Netherlands, New Zealand, Russia, Singapore, South Korea, United Kingdom, USA
  • -
  • October 1 2013

The UK government has launched a legal challenge with the European Courts of Justice (ECJ) on the remuneration provisions under the Capital

2014 what is on the horizon for the insurance industry?

  • Norton Rose Fulbright LLP
  • -
  • Asia-Pacific, Australia, Canada, China, European Union, France, Germany, Hong Kong, South Africa, United Kingdom, USA
  • -
  • February 3 2014

The Law Commissions will publish a draft Bill to amend aspects of insurance contract law which will impact commercial insureds. The Bill is likely to

International regulatory update 24 28 February 2014

  • Clifford Chance LLP
  • -
  • European Union, Germany, Global, Hong Kong, United Kingdom, USA
  • -
  • March 3 2014

EU Parliament and Council negotiators have reached an agreement on the proposed directive amending Directive 200965EC on the coordination of laws

Bitcoin - turbulent waters - part seven

  • Dorsey & Whitney LLP
  • -
  • China, European Union, Hong Kong, Japan, Singapore, United Kingdom, USA
  • -
  • March 4 2014

"Virtual currencies", and bitcoin in particular, continued to attract a lot of attention. The sudden demise of Mt. Gox (Japan), one of the largest

Patent term extensions and regulatory exclusivities for pharmaceuticals in Asia and South America

  • Morrison & Foerster LLP
  • -
  • Argentina, Brazil, Chile, China, Hong Kong, Japan, Malaysia, Mexico, Philippines, South Korea, Thailand, USA, Vietnam
  • -
  • June 27 2012

Patent protection for pharmaceutical products has an impact on the pharmaceutical market and innovation